Новая коронавирусная инфекция (COVID-19) и система органов пищеварения

Цель настоящего обзора заключается в изложении современных данных о поражении органов пищеварительной системы при новой коронавирусной инфекции (COVID-19).

Основные положения. Помимо признаков поражения дыхательной системы при COVID-19 наблюдаются желудочно-кишечные симптомы (тошнота, рвота, диарея), которые могут предшествовать появлению респираторных симптомов и выходить на первый план в клинической картине заболевания. Больные с хроническими воспалительными заболеваниями кишечника, получающие иммуносупрессивную терапию, входят в группу повышенного риска развития COVID-19. При новой коронавирусной инфекции могут отмечаться признаки поражения печени с повышением активности трансаминаз.

Заключение. Вопросы о связи поражений органов пищеварения с COVID-19 остаются недостаточно изученными и требуют дальнейших исследований.

1. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». URL: rosminzdrav.ru/ministry/med_covid19.

2. Gu J., Han, B., Wang J. COVID-19: gastrointestinal manifestations and potential fecal–oral transmission. Gastroenterology. 2020;158(6):1518–19. DOI: 10.1053/j.gastro.2020.02.054.

3. Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 Mar 5;382(10):929–36. DOI: 10.1056/NEJMoa2001191

4. Xiao F., Tang M., Zheng X. Liu Y., Li X., Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020; 158(6):1831–33. DOI:10.1053/j.gastro.2020.02.055

5. Zhang W., Du R.H., Li B., Xu D., Wang J., Li Z., Lin J. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020;9(1):386–9. DOI:10.1080/22221751.2020.1729071

6. Tang A., Tong Z.D., Wang H.L., Dai Y.X., Li K.F., Liu J.N., et al. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerg Infect Dis. 2020;26(6):1337–39. DOI: 10.3201/eid2606.200301.

7. Young B.E., Ong S.W.X., Kalimuddin S., Low J.G., Tan S.J., Loh J., et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488–94. DOI:10.1001/jama.2020.3204

8. Chan K.H., Poon L.L., Cheng V.C., Guan Y., Hung I.F., Kong J., et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis. 2004;10(2):294–9. DOI:10.3201/eid1002.030610

9. Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X., et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020;5(5):434–35. DOI: 10.1016/S2468-1253(20)30083-2

10. To K.K.W., Tsang O.T.Y., Yip C.C.Y., Chan K.H., Wu T.C., Chan J.V.C., et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020; 12:149. DOI: 10.1093/cid/ciaa149

11. Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395(10224):565–74. DOI: 1016/S0140-6736(20)30251-8

12. Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798):270–273. DOI: 10.1038/s41586-020-2012-7

13. Liang W., Feng Z., Rao S., Xiao O., Xue X., Lin Z., et al. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. 2020;69(6):1141–43. DOI: 10.1136/gutjnl-2020-320832

14. Guan W.-J., Ni Z.-Y., Hu Y., Liang W.H., Ou C.Q., He J.X., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. DOI:10.1056/NEJMoa2002032

15. Pan L., Mu M., Ren H. G., Yang P., Sun Y. Wang R., et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol, 2020;115(5):766–73. DOI: 10.14309/ajg.0000000000000620

16. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–69. DOI:10.1001/jama.2020.1585

17. Lin L., Jiang X., Zhang Z., Huang S., Zhang Z., Fang Z., et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020; 69(6):997–1001 DOI: 10.1136/gutjnl-2020-321013

18. Song Y., Liu P., Shi X.L., Chu J.L., Zhang J., Xia J., et al. SARS-CoV-2 induced diarrhea as onset symptom in patient with COVID-19. Gut. 2020;69(6):1143–44. DOI: 10.1136/gutjnl-2020-320891

19. Liu K., Fang Y.-Y., Deng Y., Liu W., Wang M.-F., Ma J.-P.,et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J 2020;133(9):1025–31. DOI: 10.1097/CM9.0000000000000744

20. Ungaro R.C., Sullivan T., Colombel J.-F., Patel G. What should gastroenterologists and patients know about COVID-19? Clin Gastroenterol Hepatol. 2020;18(7):1409–11. DOI: 10.1016/j.cgh2020.03.02

21. Jin X., Lian J.-S., Hu J.-H., Gao J., Zheng L., Zhang Y.-M., et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002–09. DOI:10.1136/gutjnl-2020-320926

22. Hormati A, Shahhamzeh A, Afifian M, Khodadust F, Ahmadpour S. Can COVID-19 present unusual GI symptoms? J Microbiol Immunol Infect. 2020. DOI:10.1016/j.jmii.2020.03.020

23. Mazza S., Sorce A., Peyvandy F., Vecchi M., Caprioli F. A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis. Gut. 2020;69(6):1148–49. DOI: 10.1136/gutjnl-2020-321183

24. Mao, R., Liang, J., Shen J., Ghosh S., Zhu L.-R., Yang H., et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020;5(5):425–27. DOI: 10.1016/S2468-1253(20)30076-5

25. Rubin D.T., Abrey M.T., Rai V., Siegel C.A. International Organization for the Study of Inflammatory Bowel Disease. Management of Patients with Crohn’s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting. Gastroenterology. 2020; S0016-5085(20)30465-0. DOI: 10.1053/j.gastro.2020.04.002

26. Chai X., Hu L., Zhang Y., Han W., Lu Z., Ke A., et al. Specific ACE2 Expression in cholangiocytes COVID-19 may cause liver damage after 2019-nCoV infection. bioRxiv. 2020; DOI:10.1101/2020.02.03.931766

27. Xu J., Helfand B. Genetic risk score linked with younger age diagnosis of prostate cancer. Oncology Times. 2020;42(6):8,36. DOI:10.1097/01.cot.0000658832.18056.12

28. Albillos A., Lario M., Álvarez-Mon M. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance. J Нepatol. 2014;61(6):1385–96. DOI:10.1016/j.jhep.2014.08.010

29. Boettler T., Newsome P.N., Mondelli M.U., Matitic M., Cordeo E., Cornberg M., et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep. 2020;2(3):100113. DOI:10.1016/j.jhepr.2020.100113

30. Fan Z., Chen L., Li J., Tian C., Zhang Y., Huang S., Liu Z., Cheng J. Clinical Features of COVID-19-Related Liver Damage. 2020. Available at SSRN 3546077. DOI:10.2139/ssrn.3546077

31. Chen N., Zhou M., DongX., Qu J., Gong F., Han Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507–13. DOI:10.1016/S0140-6736(20)30211-7

32. Ong J., Young B.E., Ong S. COVID-19 in gastroenterology: a clinical perspective. Gut. 2020;69(6):1144–45. DOI: 10.1136/gutjnl-2020-321051.

33. Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., et al. Patholigical findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420–2. DOI: 10.1016/S2213-2600(20)30076-X

34. Li X., Geng M., Peng Y., Meng L., Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 2020;10(2):102–8. DOI: 10.1016/j.jpha.2020.03.001.

35. Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S, Manson J.J. COVID-19: consider cytokine storm syndromes and immunosupression. Lancet. 2020;395(10229):1033–34. DOI:10.1016/S0140-6736(20)30628-0.

36. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet.2020;395(10229):1054–62. DOI:10.1016/S0140-6736(20)30566-3.

37. https://www.foodnavigator-asia.com/Article/2020/03/17/Fight-COVID-19-with-dairy-China-industry-associations-issue-consumption-guidelines-to-build-immuneresistance?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright

38. WHO. Coronavirus disease (COVID-19) advice for the public: Myth busters [Internet]. WHO: WHO; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters

39. British Dietetic Association. COVID-19 / Coronavirus — Advice for the General Public: «Can I boost my immune system through my diet?» 16 Mar 2020 [updated April 14 2020]. BDA: BDA; Available from https://www.bda.uk.com/resource/covid-19-corona-virus-advice-for-the-general public.html

40. WHO. Food and nutrition tips during self-quarantine [Internet]. WHO: WHO; 2020. Available from: http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov-technical-guidance/food-and-nutrition-tips-during-self-quarantine